Alphagan, Brimonidine Newswire

Alphagan, Brimonidine Newswire

Comprehensive Real-Time News Feed for Alphagan, Brimonidine (generic).

Results 1 - 13 of 13 in Alphagan, Brimonidine (generic)

  1. Perrigo Announces Tentative FDA Approval For Generic Version Of Suprep Oral Solution And...Read the original story w/Photo

    Tuesday | Freshnews

    Perrigo Company plc today announced it has received tentative approval from the U.S. Food and Drug Administration for the generic version of SuprepA oral solution. The drug is indicated for the treatment of cleansing of the colon in preparation for colonoscopy in adults.

    Comment?

  2. Perrigo Announces Tentative FDA Approval For Generic Version Of...Read the original story

    Monday Aug 22 | BioSpace

    Perrigo Announces Tentative FDA Approval For Generic Version Of Suprep Oral Solution And Confirms Patent Challenge For Generic Version Of Mirvaso Gel /PRNewswire/ -- Perrigo Company plc today announced it has received tentative approval from the U.S. Food and Drug Administration for the generic version of SuprepA oral solution. The drug is indicated for the treatment of cleansing of the colon in preparation for colonoscopy in adults.

    Comment?

  3. Pharma Leader Series: Top 25 Ophthalmic Drug Manufacturers 2016-2026Read the original story

    Jun 10, 2016 | Freshnews

    What can be expected from the ophthalmic drugs market ]? Which companies are going to be most successful in the next 10 years? Which therapeutic areas are going to grow at the fastest rates? This visiongain [https://www.visiongain.com ] report shows you potential revenues to 2026, assessing data, trends, opportunities and prospects in the market. Our 220-page report provides 160 tables, charts, and graphs.

    Comment?

  4. Galderma launches new Mirvaso Gel pump dispenserRead the original story w/Photo

    May 20, 2016 | Drug Store News

    Galderma Laboratories announced Thursday that it had launched a new pump dispenser system for its Mirvaso topical gel. The gel treats facial redness associated with rosacea and the new pump dispenses a consistent dose with each use.

    Comment?

  5. Galderma Laboratories Announces Availability Of New Mirvaso...Read the original story

    May 18, 2016 | BioSpace

    Galderma Laboratories, L.P., a global leader focused on medical treatment options in dermatology and skin health and the maker of Cetaphil , today announced the availability of a new pump dispenser design for Mirvaso Topical Gel, 0.33%* for the treatment of the persistent facial redness associated with rosacea. The Mirvaso Gel Pump is now available by prescription to patients in pharmacies nationwide. 1 comment

  6. Galderma Laboratories Announces Availability of New Mirvaso...Read the original story

    May 19, 2016 | Freshnews

    Galderma Laboratories, L.P., a global leader focused on medical treatment options in dermatology and skin health and the maker of Cetaphil , today announced the availability of a new pump dispenser design for Mirvaso Topical Gel, 0.33%* for the treatment of the persistent facial redness associated with rosacea. The Mirvaso Gel Pump is now available by prescription to patients in pharmacies nationwide.

    Comment?

  7. Venlafaxine-induced rise in intraocular pressure describedRead the original story w/Photo

    May 9, 2016 | PhysOrg Weblog

    In a case report published online April 30 in Clinical & Experimental Ophthalmology , venlafaxine-induced increase in intraocular pressure is described in a patient with open angle glaucoma. Verona E. Botha, M.B., Ch.B., from Waikato District Health Board in Hamilton, New Zealand, and colleagues describe a 65-year-old Caucasian male with chronic open angle glaucoma who started venlafaxine 225 mg once daily for a major depressive episode.

    Comment?

  8. Galderma Encourages Rosacea Sufferers to Ditch Their MakeupRead the original story

    May 5, 2016 | Global Cosmetic Industry

    A new project is encouraging rosacea sufferers to stop covering up the problem with makeup and confront their condition directly. The chronic skin condition is related to other health issues such as cardiovascular disease.

    Comment?

  9. Ita s Time to a oeFacea the Facts: New Data Suggests Rosacea Is More Than Just Skin DeepRead the original story

    Apr 27, 2016 | Business Wire

    Galderma Laboratories, L.P. and the National Rosacea Society Launch Campaign/Contest to Educate Public on Rosacea and Help Sufferers Feel More Confident in their Skin )--Recent research suggests that rosacea, a common, chronic skin condition affecting 16 million Americans, may be linked to negative effects on the body as a whole, not just the face. It's believed that possibly due to its inflammatory nature, people with rosacea are at an increased risk of a number of other serious health related issues, including cardiovascular disease and other forms of vascular disease, much like psoriasis patients.

    Comment?

  10. A novel de novo Myocilin variant in a patient with sporadic juvenile open angle glaucomaRead the original story w/Photo

    Apr 13, 2016 | BioMed Central

    Glaucoma is a leading cause of irreversible blindness. Pathogenic variants in the Myocilin gene cause juvenile open angle glaucoma in 8-36 % of cases, and display an autosomal dominant inheritance with high penetrance.

    Comment?

  11. From 'Rosy' to Redness Relief: One Rosacea Patient's Journey to Clearer SkinRead the original story w/Photo

    Dec 1, 2015 | ParsonsSun.com

    In his 24 years as a police officer, skincare has not been a common topic of conversation among Jarrard and his colleagues.

    Comment?

  12. Allegro Ophthalmics LLC Names As Chief Financial Officer And Vice...Read the original story

    Oct 20, 2015 | BioSpace

    Allegro Ophthalmics, LLC, a biotechnology company focused on the development of therapies to treat vitreoretinal diseases, today announced that Scott Cooper has joined the company as Chief Financial Officer and Vice President of Business Development, and that Mohamed Genead, MD, has been named Executive Medical Director. "We are delighted to welcome Scott and Mohamed to Allegro," says Hampar Karageozian, MSc, MBA, Co-Founder and Chief Executive Officer, Allegro Ophthalmics.

    Comment?

  13. Allegro Ophthalmics Names Scott Cooper as Chief Financial Officer and ...Read the original story

    Oct 21, 2015 | Freshnews

    Allegro Ophthalmics, LLC, a biotechnology company focused on the development of therapies to treat vitreoretinal diseases, today announced that Scott Cooper has joined the company as Chief Financial Officer and Vice President of Business Development, and that Mohamed Genead, MD, has been named Executive Medical Director. "We are delighted to welcome Scott and Mohamed to Allegro," says Hampar Karageozian, MSc, MBA, Co-Founder and Chief Executive Officer, Allegro Ophthalmics.

    Comment?